Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease

Movement Disorders : Official Journal of the Movement Disorder Society
Francesca Romana PezzellaGiuseppe Meco

Abstract

Hedonistic homeostatic dysregulation (HHD) is a neuropsychiatric disorder recently described in Parkinson's disease (PD), which is characterized by self-medication and addiction to dopaminergic drugs. To understand the prevalence of this disorder, we screened 202 PD patients attending our movement disorder unit for HHD. The clinical features of the patients identified as affected by this syndrome were then compared with those of control PD patients in an attempt to ascertain the possible risk factors for HHD. Results showed 7 subjects who fulfilled the HHD criteria. The analysis of a case-control study showed a significant correlation between HHD and a previous history of mood disorders, and the use of dopamine agonists, either in monotherapy or in combination. The prevalence of HHD in our study is similar to the one reported in the United Kingdom by the authors who first described this syndrome in PD. Of interest, our patients showed a somewhat different pattern of the disorder, suggesting that cultural and environmental factors may play a role in the phenomenology of HHD.

References

Jan 1, 1992·British Journal of Addiction·M Soyka, D Huppert
Jan 1, 1989·Neuropathology and Applied Neurobiology·W R Gibb, A J Lees
Jan 1, 1985·Clinical Neuropharmacology·P A Nausieda
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Jul 1, 1984·Pharmacopsychiatry·S Priebe
Jul 1, 1983·Pharmacopsychiatria·H P Vogel, R Schiffter
Aug 28, 1997·Nature·M G SpillantiniM Goedert
Jun 20, 1998·Neurology·R A MaricleJ G Nutt
Mar 23, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·G GiovannoniA J Lees
Sep 29, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·J A MolinaF Bermejo
Jun 8, 2001·Clinical Neuropharmacology·U GschwandtnerP Fuhr
May 1, 2002·Clinical Neuropharmacology·Mario ZappiaAldo Quattrone
Sep 7, 2002·Der Nervenarzt·U MüllerH J Gertz
Oct 18, 2002·Neuron·Wolfram Schultz
Dec 5, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D J Burn
Jun 20, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Marieke DekkerCornelia van Duijn
Jul 19, 2003·Current Opinion in Neurology·Simone A Betchen, Michael Kaplitt
Nov 5, 2003·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·F R PezzellaG Meco

❮ Previous
Next ❯

Citations

Apr 21, 2007·Current Treatment Options in Neurology·Wendy R Galpern, Mark Stacy
Jun 10, 2011·European Journal of Clinical Pharmacology·Nadège RouveUNKNOWN French Association of Regional PharmacoVigilance Centres
Dec 1, 2012·Journal of Neural Transmission·Dénes ZádoriLászló Vécsei
May 22, 2010·Molecular Psychiatry·A Fasano, I Petrovic
Nov 30, 2007·Nature Clinical Practice. Neurology·Marc N PotenzaDaniel Weintraub
Apr 2, 2010·Journal of Sex Research·Meg S Kaplan, Richard B Krueger
Jul 5, 2008·The Nurse Practitioner·Mickie Welsh
Mar 12, 2008·The Neurologist·William Stamey, Joseph Jankovic
May 7, 2010·The Neurologist·Gülay KenangilEthem Erginöz
Oct 3, 2007·Clinical Neuropharmacology·Erika D Driver-DunckleyCharles H Adler
Sep 18, 2008·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·David KnobelAlexandre Berney
Apr 17, 2008·Psychiatry and Clinical Neurosciences·Diana M E Torta, Lorys Castelli
Nov 2, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H-L ChiangY-R Wu
Dec 3, 2011·Neurology Research International·Beatriz De la Casa-Fages, Francisco Grandas
May 24, 2011·Parkinson's Disease·Ariane Park, Mark Stacy
Dec 17, 2008·Revue neurologique·M C Scheiber-Nogueira
Dec 23, 2015·Assay and Drug Development Technologies·Joel A Morales-RosadoEric W Klee
Nov 2, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Melissa J Nirenberg, Cheryl Waters
Nov 16, 2006·Annals of the New York Academy of Sciences·Francesca BiagioniFrancesco Fornai
Apr 7, 2016·Current Neurology and Neuroscience Reports·Jeffrey W Cooney, Mark Stacy
May 16, 2014·Journal of Neurology·Emke MaréchalPatrick Cras
Oct 18, 2016·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Jacob TaylorGregory M Pontone
Jun 26, 2009·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Shen-Yang LimAndrew H Evans
May 2, 2013·Therapeutic Advances in Neurological Disorders·Tiago A MestreJanis Miyasaki
Dec 11, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Isabelle Beaulieu-Boire, Anthony E Lang
Oct 18, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Maurizio AvanziFlavio Bonfà
Oct 13, 2006·Addiction·Carlos TéllezPablo Venegas
Oct 3, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Laura Silveira-MoriyamaAndrew J Lees
Nov 4, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Hideto MiwaTomoyoshi Kondo
Jan 30, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Lilach EphratySharon Hassin-Baer
May 31, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Javier PagonabarragaJaime Kulisevsky
Jul 11, 2007·Current Opinion in Neurology·Valerie VoonTeri Thomsen
Aug 23, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Martine VisserJacobus J van Hilten
Dec 11, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Ioannis U IsaiasAngelo Antonini
Apr 12, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Joseph Jankovic
Jun 16, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Andrew H EvansMark Stacy
Nov 13, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Gabriel RobertOlivier Blin
Feb 27, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Shen-Yang Lim, Anthony E Lang
Jul 23, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Katherine Grosset, Donald Grosset
Nov 8, 2008·Annals of the New York Academy of Sciences·Shen-Yang LimJanis M Miyasaki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
J MiyasakiValerie Voon
Movement Disorders : Official Journal of the Movement Disorder Society
Maurizio AvanziFlavio Bonfà
© 2021 Meta ULC. All rights reserved